WAM
RVPH

Weiss Asset Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Weiss Asset Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,703
Closed -$984K – 306
2019
Q4 		$984K Hold
4,703
– – 0.07% 108
2019
Q3 		$974K Hold
4,703
– – 0.08% 102
2019
Q2 		$985K Sell
4,703
-11,892
-72% -$2.42M 0.06% 135
2019
Q1 		$3.34M Buy
16,595
+6,345
+62% +$1.27M 0.26% 78
2018
Q4 		$2.02M Buy
+10,250
New +$2.01M 0.14% 99

Other funds holding RVPH

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return

Weiss Asset Management's RVPH Position: Q1 2020 in Review

Weiss Asset Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2020, closing a stake of 4,703 shares — an estimated $984K sold.

Weiss Asset Management first reported a position in RVPH in Q4 2018 and held it in 5 quarters. The position peaked at $3.34M in Q1 2019. 24 funds tracked by Wall St. Rank hold RVPH as of Q1 2020.

  • Weiss Asset Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2020 after selling out during the quarter.
  • Weiss Asset Management sold 4,703 REVIVA PHARMA HLDGS INC shares in Q1 2020, an estimated $984K.
  • Weiss Asset Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 5 quarters.
  • Weiss Asset Management's REVIVA PHARMA HLDGS INC position peaked at $3.34M in Q1 2019.
  • 24 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2020.

Based on Weiss Asset Management's 13F filing for Q1 2020, filed 14 May 2020.